These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7651370)

  • 1. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
    Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
    Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
    Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
    Gharagozloo P; Lazareno S; Popham A; Birdsall NJ
    J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
    Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ
    Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S; Dolezal V; Popham A; Birdsall NJ
    Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
    J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.
    Lazareno S; Gharagozloo P; Kuonen D; Popham A; Birdsall NJ
    Mol Pharmacol; 1998 Mar; 53(3):573-89. PubMed ID: 9495826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
    Richardson RM; Mayanil CS; Hosey MM
    Mol Pharmacol; 1991 Dec; 40(6):908-14. PubMed ID: 1758442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
    Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors.
    Olianas MC; Adem A; Karlsson E; Onali P
    Eur J Pharmacol; 2004 Mar; 487(1-3):65-72. PubMed ID: 15033377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
    Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
    Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of functionally selective allosteric interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae.
    Stewart GD; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Aug; 78(2):205-14. PubMed ID: 20466821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
    Jakubík J; El-Fakahany EE; Dolezal V
    Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC; Challiss RA; Nahorski SR
    Br J Pharmacol; 2001 Feb; 132(4):950-8. PubMed ID: 11181437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.